Associate Professor of Medicine, University Minn
Hematology
Dr. Vicki A. Morrison, MD
|
|
Give Review
Dr. Vicki A. Morrison practices Hematology. She studied medicine at University of Wisconsin School of Medicine and Public Health. She received awards:"Regional Top Doctor". Vicki Morrison is a published doctor. She has 55 papers published. The most current publication "Personalized risk prediction for event-free survival at 24 months in patients with diffuse large b-cell lymphoma."
Publications
- Personalized risk prediction for event-free survival at 24 months in patients with diffuse large b-cell Lymphoma.
- Long-term Persistence of Zoster Vaccine Efficacy.
- Approach to therapy of diffuse large B-cell Lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.
- Diffuse large B-cell Lymphoma in the elderly: Impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Soci...
- Modeling the durability of ZOSTAVAX(®) vaccine efficacy in people ≥60 years of age.
- Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies.
- Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).
- Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
- The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia.
- Safety of Zoster Vaccine in Elderly Adults Following Documented Herpes Zoster.
- Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell Lymphoma: an analysis of two phase II trials.
- Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of s...
- The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of a...
- Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
- Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up...
- Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.
- Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
- Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Su...
- Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.
- Non-Hodgkin's Lymphoma in the elderly. Part 2: treatment of diffuse aggressive Lymphomas.
- Non-Hodgkin's Lymphoma in the elderly. Part 1: Overview and treatment of follicular Lymphoma.
- Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in com...
- Management of infectious complications in patients with chronic lymphocytic leukemia.
- Telephone monitoring of distress in patients aged 65 years or older with advanced stage Cancer: a Cancer and leukemia group B study.
- Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell Lymphoma.
- Infectious complications of chronic lymphocytic leukemia.
- Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
- Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an ...
- An overview of the management of infection and febrile neutropenia in patients with Cancer.
- Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic l...
- Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergrou...
- Emerging fungal pathogens in patients with hematologic Malignancies and marrow/stem-cell transplant recipients.
- Infections in patients with leukemia and Lymphoma.
- A genome-wide survey of structural variation between human and chimpanzee.
- Mutations and molecular variants of the NBS1 gene in non-Hodgkin Lymphoma.
- A functional variant of IRS1 is associated with type 1 diabetes in families from the US and UK.
- Myeloid growth factors: to use or not to use, that is the question.
- Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocyt...
- Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin''s Lymphoma receiving CHOP chemotherapy.
- The role of caspofungin and the echinocandins in the antifungal armamentarium.
- Echinocandin antifungals: review and update.
- Caspofungin: an overview.
- International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
- Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
- Impact of primary prophylaxis on febrile neutropenia within community practices in the US.
- Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.
- Evolution of R-CHOP therapy for older patients with diffuse large B-cell Lymphoma.
- Therapeutic approaches to non-Hodgkin''s Lymphoma in the elderly patient.
- Post-transplant lymphoproliferative disorders following solid-organ transplantation.
- Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.
- Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell Lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4...
- Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.
- Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.
- Review of the pharmacology and clinical studies of micafungin.
Schools
University of Wisconsin Madison
Naval Regl Med Center
Bethesda Naval Hospital
University Minn Hospital
Conditions Treated
- Anemia
- Bladder Cancer
- Esophageal Cancer
- Hodgkin's Disease
- View All
Doctors Specialties
- Infectious Disease Medicine
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Minnesota at Fairview -
National Capital Consortium -
Naval Medical Center -
University of Wisconsin School of Medicine and Public Health
Helpful Reviews
Similar Doctors
|
|
Dr. Anne-Marie Leuck, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Dittes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omobosola O. Akinsete, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Gavin, MD |
|
|
Dr. Cassandra C. Harrison, MD |
|
|
Dr. Seikei Hibino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon D. Luikart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan I. Ravdin, MD |
|
|
Dr. Mark A. Wilkowske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kendra L. Kubiak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott W. Sorensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexa A. Pragman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Manion, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Linden, MD
This Doctor is OpenDoctor Recommended.
|